6.13
+0.21(+3.55%)
Currency In USD
| Previous Close | 5.92 |
| Open | 6.06 |
| Day High | 6.26 |
| Day Low | 5.9 |
| 52-Week High | 11.41 |
| 52-Week Low | 1.73 |
| Volume | 406,333 |
| Average Volume | 653,215 |
| Market Cap | 190.04M |
| PE | -3.05 |
| EPS | -2.01 |
| Moving Average 50 Days | 5.9 |
| Moving Average 200 Days | 6.87 |
| Change | 0.21 |
If you invested $1000 in Sagimet Biosciences Inc. (SGMT) since IPO date, it would be worth $384.33 as of February 26, 2026 at a share price of $6.13. Whereas If you bought $1000 worth of Sagimet Biosciences Inc. (SGMT) shares 2 years ago, it would be worth $851.39 as of February 26, 2026 at a share price of $6.13.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
GlobeNewswire Inc.
Feb 05, 2026 12:00 PM GMT
SAN MATEO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that man
Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne
GlobeNewswire Inc.
Feb 02, 2026 12:00 PM GMT
SAN MATEO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Asc
Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference
GlobeNewswire Inc.
Jan 08, 2026 12:00 PM GMT
SAN MATEO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that it